Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

GWP.L (GWP) Share News

UK MIDDAY BRIEFING: BOE Policy Makers Still Unanimous

18th Jun 2014 11:47

LONDON (Alliance News) - Bank of England policymakers unanimously decided to leave the key interest rates and asset purchase programme unchanged at the monetary policy meeting held on June 4 and 5, the minutes of the meeting showed Wednesday. <br /><br />All nine members of the Monetary Policy Read More

UK WINNERS & LOSERS: Iraq Crisis Lifts Oil Prices, Oil Companies

18th Jun 2014 11:24

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Wednesday.<br />-------<br />FTSE 100 - WINNERS<br />-------<br /><strong>Royal Dutch Shell</strong>, up 1.9%. The oil major and state-owned China National Offshore Oil Corpor Read More

GW Pharmaceuticals To Sell 1.7 Million American Depositary Shares

18th Jun 2014 08:32

LONDON (Alliance News) - GW Pharmaceuticals PLC Wednesday announced plans to sell 1.7 million American depositary shares representing GW ordinary shares, in a public offering on the NASDAQ. The price of the offering has not yet been decided. GW and some of its shareholders intend to sell th Read More

UK MORNING BRIEFING: Zoopla Prices IPO As Markets Await Central Banks

18th Jun 2014 07:21

LONDON (Alliance News) - UK shares have opened higher Wednesday, following a firm close on Wall Street and ahead of central bank announcements in the UK and US.<br /><br />There was further IPO activity Wednesday, as property website <strong>Zoopla Property</strong> Group said it will price it Read More

GW Pharmaceuticals Gets Promising Data From Epidiolex Trial

17th Jun 2014 11:55

LONDON (Alliance News) - GW Pharmaceuticals PLC said Tuesday that it had received "promising" data from physician reports on 27 children and young adults being treated in a trial with its Epidiolex drug for treatment-resistant epilepsy. The patients had a range of different epilepsy conditi Read More

GW Pharmaceuticals Drug Epidiolex Gets Fast Track Status From US FDA

6th Jun 2014 08:55

LONDON (Alliance News) - GW Pharmaceuticals PLC said Friday its Dravet syndrome treatment Epidiolex had been granted 'Fast Track' status by the US Food and Drug Administration. This status is intended to speed up the reviewing process of certain drugs that treat serious conditions or fill a Read More

GW Pharma Prepares To Launch Epidiolex Clinical Trials

7th May 2014 13:29

LONDON (Alliance News) - GW Pharmaceuticals PLC Wednesday said it expects to start a phase II/III clinical trial for developmental childhood Epilepsy drug Epidiolex in the second half of 2014, after the US Food and Drug Administration confirmed that its investigational new drug application is now Read More

UK Earnings, Trading Statements Calendar - Week Ahead

7th May 2014 05:12

Read More

MARKET COMMENT: FTSE 100 Snaps Five-Day Winning Streak, Pound Jumps

6th May 2014 15:45

LONDON (Alliance News) - The FTSE 100 lost ground Tuesday, snapping a five day winning streak as investors returned from a long weekend, over which the conflict in Ukraine continued to escalate, to some disappointing corporate news from the likes of <strong>Barclays</strong> and <strong>Balfou Read More

UK Earnings, Trading Statements Calendar - Week Ahead

6th May 2014 15:37

Read More

UK Earnings, Trading Statements Calendar - Week Ahead

6th May 2014 05:30

Read More

UK Earnings, Trading Statements Calendar - Week Ahead

2nd May 2014 15:17

Read More

UK Earnings, Trading Statements Calendar - Week Ahead

2nd May 2014 05:11

Read More

UK Earnings, Trading Statements Calendar - Week Ahead

1st May 2014 15:36

Read More

UK Earnings, Trading Statements Calendar - Week Ahead

1st May 2014 05:14

Read More

UK Earnings, Trading Statements Calendar - Week Ahead

30th Apr 2014 15:42

Read More

UK MIDDAY BRIEFING: Healthcare Stocks Lifted By Chary AstraZeneca

28th Apr 2014 11:35

LONDON (Alliance News) -<strong> AstraZeneca</strong> has led the FTSE 100 all Monday morning after US drugs giant Pfizer confirmed that it has now twice approached British peer with a takeover proposal.<br /><br />Pzifer said it is considering its options after being rebuffed for a second tim Read More

UK WINNERS & LOSERS: AstraZeneca Leads Risers; BG Group Falls

28th Apr 2014 10:48

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Monday.<br />-------<br /><strong>FTSE 100 - WINNERS</strong><br />-------<br /><strong>AstraZeneca</strong>, up 15%. US drugs giant Pfizer Inc has confirmed that it has now t Read More

GW Pharmaceuticals Cancer Pain Treatment Given Fast Track Designation

28th Apr 2014 09:33

LONDON (Alliance News) - GW Pharmaceuticals PLC said Monday that its compound Sativex had been granted a Fast Track designation by the US Food and Drug Administration, for the treatment of pain in patients with advanced cancer. The treatment is for patients whose pain is not adequately hand Read More

GW Pharmaceuticals Continuing Progress With Cannabinoid Pipeline

17th Mar 2014 12:56

LONDON (Alliance News) - GW Pharmaceuticals PLC said Monday that it has continued to make progress with its cannabinoid pipeline, as it provided an update on the progress of several of its pipeline products. The company completed a Phase I clinical trial of candidate GWP42006 to treat epile Read More

FTSE 100 Latest
Value8,809.74
Change53.53